CLEAVAGE OF 3RD COMPLEMENT COMPONENT (C3) AND GENERATION OF SPASMOGENIC PEPTIDE, C3A, IN HUMAN-SERUM VIA PROPERDIN PATHWAY - DEMONSTRATION OF INHIBITORY AS WELL AS ENHANCING EFFECTS OF EPSILON-AMINO-CAPROIC ACID

被引：0

作者：

VOGT, W ^{[1
]}

SCHMIDT, G ^{[1
]}

LYNEN, R ^{[1
]}

DIEMINGER, L ^{[1
]}

机构：

[1] MAX PLANCK INST EXPTL MED,DEPT BIOCHEM PHARMACOL,34 GOTTINGEN,FED REP GER

来源：

JOURNAL OF IMMUNOLOGY | 1975年 / 114卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：671 / 677

页数：7

共 13 条

[1] CLEAVAGE OF THIRD COMPLEMENT COMPONENT (C3) AND RELEASE OF A SPASMOGENIC, C3-DERIVED PEPTIDE (C3A) BY EPSILON-AMINOCAPROIC ACID (EACA) IN SERUM - PROCESS INVOLVING COMPLEMENT ACTIVATING PROPERDIN SYSTEM
VOGT, W
SCHMIDT, G
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 282 : R103 - R103
[2] CLEAVAGE OF THE 3RD COMPLEMENT COMPONENT IN HUMAN-SERUM - DEMONSTRATION OF FACILITATION AND INHIBITION EFFECTS OF TRANEXAMIC ACID
PERRICONE, R
DECAROLIS, C
DESANCTIS, C
FONTANA, L
HAEMATOLOGICA, 1980, 65 (06) : 822 - 823
[3] INHIBITION OF CLEAVAGE OF THE 3RD COMPONENT OF HUMAN-COMPLEMENT (C3)BY ITS SMALL CLEAVAGE FRAGMENT, C3A - INHIBITION OCCURS WITH THE CLASSICAL-PATHWAY, BUT NOT THE ALTERNATIVE-PATHWAY, C-3 CONVERTASE
STRUNK, RC
WEBSTER, RO
MOLECULAR IMMUNOLOGY, 1985, 22 (01) : 37 - 43
[4] CLEAVAGE OF THE ISOLATED 3RD COMPONENT OF C IN NORMAL HUMAN-SERUM AND IN PATIENT SERUM WITH C-3 CONVERTING FACTORS (C-3 COF)
SCHWERTZ, R
WOLLENHAUPT, HJ
WAHN, V
ROTHER, U
IMMUNOBIOLOGY, 1985, 170 (1-2) : 85 - 85
[5] EFFECTS OF CLEAVAGE PEPTIDES, C3A AND C3AI, FROM 3RD COMPONENT OF HOG COMPLEMENT ON LEUKOCYTE ACCUMULATION AND VASCULAR-PERMEABILITY INVIVO
DAMERAU, B
HOLLERHAGE, HG
VOGT, W
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1978, 302 (01) : 45 - 50
[6] ACTIVATION OF THE 3RD COMPLEMENT COMPONENT (C-3) AND C3A GENERATION IN CARDIAC ANAPHYLAXIS - HISTAMINE-RELEASE AND ASSOCIATED INOTROPIC AND CHRONOTROPIC EFFECTS
DELBALZO, U
POLLEY, MJ
LEVI, R
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1988, 246 (03): : 911 - 916
[7] GENETIC-POLYMORPHISM AND SERUM CONCENTRATION OF PROPERDIN FACTOR-B (BF) AND 3RD COMPONENT OF COMPLEMENT (C3) IN SUHARA INDIANS IN ECUADOR
AGARWAL, DP
BENKMANN, HG
GOEDDE, HW
PATHOLOGIE BIOLOGIE, 1977, 25 (06): : 390 - 390
[8] PREPARATION OF AN R3-REAGENT (SERUM DEPLETED OF THE 3RD COMPONENT OF HUMAN COMPLEMENT-(C3)) BY IMMUNOADSORPTION - APPLICATION TO THE HEMOLYTIC ASSAY OF HUMAN-C3
FONTAINE, M
JOISEL, F
DUMOUCHEL, L
JOURNAL OF IMMUNOLOGICAL METHODS, 1980, 33 (02) : 145 - 158
[9] INTERACTIONS OF 3RD COMPONENT OF COMPLEMENT (C3) WITH CROSS-LINKED DEXTRAN .2. DEMONSTRATION OF AN ALTERNATE PATHWAY ACTIVATION AS BINDING MECHANISM OF C3 TO CROSS-LINKED DEXTRAN
KNAPP, W
ZEITSCHRIFT FUR IMMUNITATS-FORSCHUNG EXPERIMENTELLE UND KLINISCHE IMMUNOLOGIE, 1975, 149 (01): : 69 - 77
[10] USE OF EHRLICHS ASCITIC TUMOR-CELLS IN PREPARING HYPER-IMMUNE FLUID AGAINST 3RD COMPONENT (C-3) OF HUMAN-SERUM COMPLEMENT
GUPTA, AK
RAO, KM
MANJA, KS
INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 1980, 18 (05) : 532 - 533

← 1 2 →